Skip to main content

Table 3 Steroids, antibiotic and antifungals intake [n (%)] by diagnostic category

From: Repeated Aspergillusisolation in respiratory samples from non-immunocompromised patients not selected based on clinical diagnoses: colonisation or infection?

 

Total

Colonised

Aspergillosis

   

Probable

Proven

Probable + Proven

No. patients

245

106

125

14

139

Steroids intake before admission

101 (41.2)

29 (27.4)

64 (51.2)a

8 (57.1)a

72 (51.8)a

 ≥20 mg/day

59 (58.4)

15 (51.7)

40 (62.5)

4 (50.0)

44 (61.1)

 Accumulated dose >100 mg

76 (75.2)

17 (58.6)

52 (81.3)a

7 (87.5)

59 (81.9)a

 Accumulated dose >700 mg

20 (19.8)

6 (20.7)

11 (17.2)

3 (37.5)

14 (19.4)

Antibiotic treatment before admission

88 (35.9)

34 (32.1)

47 (37.6)

7 (50.0)

54 (38.8)

Antifungal treatment after culture request

141 (57.6)

31 (29.2)

96 (76.8)a

14 (100)a

110 (79.1)a

 Voriconazole as monotherapy

68 (48.2)

11 (35.5)

55 (57.3)

2 (14.3)

57 (51.8)

 Voriconazole + other antifungals

30 (21.3)

5 (16.1)

18 (18.8)

7 (50.0)

25 (22.7)

 Total patients receiving voriconazole

98 (69.5)

16 (51.6)

73 (76.1)

9 (64.3)

82 (74.5)

 Other antifungals

43 (30.5)

15 (48.4)

23 (24.0)

5 (35.7)

28 (25.5)

  1. ap ≤ 0.05 vs. colonised.